Page 52 - The prevalence of the Val66Met polymorphism in musicians: Possible evidence for compensatory neuroplasticity from a pilot study

doi:
;
bioRxiv preprint
https://doi.org/10.1101/2022.10.10.511614
this version posted October 13, 2022.
The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under a
.
CC-BY-ND 4.0 International license
16

100%

90%

80%

70%

60%

Percent 50%

40%

30%

20%

10%

0%
NA12878 NA12878 0 NA12878 125 NA12878 375 NA12878 625 NA12878 1000 NA24631 NA24631 0 NA24631 125 NA24631 375 NA24631 625 NA24631 1000
Control Control
Sample ID and UV Dosage (mJ/cm )
2

% Call Rate % Heterozygosity

Figure 3
Heterozygosity and call rate of degraded samples, averaged across two replicates for each dosage. Sample IDs are listed as the amount of dosage for each (e.g., 125=125
mJ/cm dosage). All samples met the total intensity threshold with the exception of one replicate of NA12878 with 1000 mJ/cm of UV-C degradation. The red lines
2
2
represent the heterozygosity upper and lower bounds.

Developmental Validation of the Illumina Infinium Assay using the Global Screening Array (GSA) on the iScan System for use in Forensic Laboratories